title: Fluorodeoxyglucose-PET/Computed Tomography-Guided Biopsy.
abstract: PET/computed tomography (CT) combines the anatomic information from CT with PET metabolic characterization. 18F-fluorodeoxyglucose (FDG) PET is helpful to differentiate malignant lesions from benign ones, that usually show lower or no uptake. However, active inflammation or infectious disease might also present FDG uptake. Studies confirm the great value of PET/CT as the imaging method of choice for guiding biopsy procedures. Novel PET radiopharmaceuticals are also being investigated for guiding biopsies.
authors.affiliation: Quanta Diagnóstico e Terapia, Diagnostic and Therapy Clinic, Rua Almirante Tamandaré 1000, 4100400, Alto da XV - Curitiba, Paraná, Brazil. Electronic address: cercijuliano@hotmail.com.
authors.forename: Juliano J
authors.initials: JJ
authors.lastname: Cerci
authors.affiliation: Nuclear Medicine Unit, S. Orsola-Malpighi Hospital, Pavillion 30, via Massarenti 9, 40138, Bologna, Italy.
authors.forename: Elena
authors.initials: E
authors.lastname: Tabacchi
authors.affiliation: Quanta Diagnóstico e Terapia, Diagnostic and Therapy Clinic, Rua Almirante Tamandaré 1000, 4100400, Alto da XV - Curitiba, Paraná, Brazil.
authors.forename: Mateos
authors.initials: M
authors.lastname: Bogoni
mesh_terms: D019788:Fluorodeoxyglucose F18; D006801:Humans; D061705:Image-Guided Biopsy / Q000009:adverse effects / Q000379:methods; D008297:Male; D064847:Multimodal Imaging / Q000379:methods*; D049268:Positron-Emission Tomography / Q000379:methods*; D019275:Radiopharmaceuticals; D014057:Tomography, X-Ray Computed / Q000379:methods*
chemical_list: D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18
keywords: Cancer; FDG-PET/CT; Guided biopsy; Oncology; PET/CT